Pharmaceutics International, Inc.
10819 Gilroy Road
18 articles with Pharmaceutics International, Inc.
Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) headquartered in Hunt Valley, Maryland, is pleased to announce the launch of Busulfan Injection, 6mg/mL in 10mL vials, in partnership with Athenex Pharmaceuticals, Sungen Pharma and Chemwerth.
The EIRs are related to General and Pre-Approval Inspections (PAIs) that occurred between October 23rd and November 9th, 2018, of non-sterile and sterile drug production facilities.
Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) today announced it has won a CMO Leadership Award.
Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) headquartered in Hunt Valley, Maryland, is pleased to announce the appointment of Kurt R. Nielsen, Ph.D., to the position of President and CEO, effective immediately.
Pii is the exclusive manufacturer of Bretylium Tosylate for Academic Pharmaceuticals, Inc., who is currently seeking a commercial partner to license and launch the drug product in the U.S.
Mr. Nowak joins Pii with nearly 30 years of experience in the pharmaceutical industry
Pii and its Partners Received FDA Market Approval for Seven Products and Commercially Launched 6 Products in 2017
In early 2017, Pii conducted a cGMP baseline risk assessment and implemented remediation initiatives to enhance its cGMP systems.
Pharmaceutics International, Inc. Release: Matthew Giles, Vice President, Data Integrity And Quality Control
Pharmaceutics International, Inc. Successfully Completes European Medicines Evaluation Agency and FDA Inspection
Pharmaceutics International, Inc. Expands Drug Formulation and Manufacturing Capabilities with Hot Melt Extrusion Technology
Pharmaceutics International, Inc. Announces Appointment of Rampurna Prasad Gullapalli, Ph.D. as Vice President of Drug Delivery Technologies
Pharmaceutics International, Inc. Announces Appointment of Tony Horton as Vice President of Quality Assurance
Pharmaceutics International, Inc. And NexMed Enter into Strategic Collaboration Agreement for NexMed’s NexACT(R) Drug Delivery Platform